1. Home
  2. SENEB vs SCLXW Comparison

SENEB vs SCLXW Comparison

Compare SENEB & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seneca Foods Corp. Class B

SENEB

Seneca Foods Corp. Class B

HOLD

Current Price

$159.83

Market Cap

880.5M

ML Signal

HOLD

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.12

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SENEB
SCLXW
Founded
1949
N/A
Country
United States
United States
Employees
6895
30
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
880.5M
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SENEB
SCLXW
Price
$159.83
$0.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
275.0
6.1K
Earning Date
02-05-2026
03-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.93
N/A
Revenue Growth
N/A
22.02
52 Week Low
$90.19
$0.04
52 Week High
$164.98
$0.64

Technical Indicators

Market Signals
Indicator
SENEB
SCLXW
Relative Strength Index (RSI) 77.25 51.17
Support Level $108.68 $0.09
Resistance Level N/A $0.18
Average True Range (ATR) 0.07 0.02
MACD 3.01 0.00
Stochastic Oscillator 88.54 73.63

Price Performance

Historical Comparison
SENEB
SCLXW

About SENEB Seneca Foods Corp. Class B

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: